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randomization to oral ARG or placebo (3 grams three times a day). Coronaty
artery diameter was measured by quantitative coronary angiography and
coronary blood flow (CBF) was calculated utilizing mronary flow Doppler.
There was no difference between the groups in age, degree of coronary
atherosclerosis, gender or coronary artery disaesa risk facfora.
% A CBF L.arginine(n= 9) Placebo (n= 9)
Baseline –18*7 –lZ&e
6 months follow-up 150+40” -5 *12
*p< 0,05vs, Placebo and baaeline. % A CBFto ecetylcholine(10-4 M)
Thisstudy demonstrates that chronic L-arginine administration in humans
restores coronary endothelial function. This study suppotts a pmsible role
for ARG in the treatment of coronary endothelial dysfunction in humans.
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m7435 AlteredEndotheliumDependentVasomotionAfterCardiacTransplantation;Correlationto Early
MvocardialExpressionof InducibleandConstltutive
NkricOxideSynthasesandEndothelininHumans
S.M. Wildhirt, M. Weis, C. Schulze, G. Rieder, Q. Enders, R. Arendt,
W.P.Wolf, U. Wilbert-Lampen, P. Ueberfuhr, W.v. Scheidt, B. Reichart.
Oepta. of Cardiac Sugary Cardiology and Surgical Research, University
Hoapltal, Munich, Germany
Objective: Endotheiium dependent vasomotion is impaired in cardiac trans-
plant racipiants and precedes transplantvaeculopathy.The present atudy
investigated the expression of vaaoacfive substances (iNOS, cNOS, En-
dothelin) early after transplantation (HTx) and their correlation to altered
vaaomotion. Methods: Coronaty flow raaerve (CFR) was assessed by maa-
surlng coronay blood flow at rest and in response to endofhellum depndent
vaecdilator acetylchollne (30 xglmin) using Doppler-flowke. Endomyooar-
dlal biopsies were taken 33.7 + 3.6 days after HTx In 17 pts for total RNA
extraction. RT-PCR was petiormed using specific primemfor iNOS, cNOS,
Endothelin (ET) and the housekeeping GAP-DH. Patients (Pt) were kept on
standard immunosuppresaion and were excluded when signa of rajacfion or
infection occurred. Resu/ts: CFR greater than 2.0 was considered normal.
Twelve pts. showed normal CFR (2.8 * 0.2). Five Pt presentad with a sig-
nificantly impaired CFR (1.5 + 0.19, p = 0.0006). An equal concentration of
cDNA was assured by the amplification of GAP-DH. Increased amounts of
mRNA tranacripta for iNOS-gene was obtained in transplants with impaired
CFR; it mrrelated with the degree of impaired CFR. cNOS-gene appeared
to be attenuated in Pt with impaired CFR, whereas ET-gene expression did
not differ among groups. Conckrsions: The results suggest that an earfy
expression of iNOS gene, in addition to attenuated cNOS-gane expression
correlates with impaired endothelial funclion. Modulation of vasoactive sub-
stances might be beneficial in the treatment of endothelial dysfunction early
after HTx.
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m7436 Abnormalendotheiin-1sensitivitywithpreservation
of nitricoxideaotivityinpatientswithsyndromeX
D.E. Newby, N.A. Bocn, D.J. Webb. Univeraityof Edinbugh, Edinburgh, UK
Theinduotion of’’microvaacular angina” in patients with syndromeX has been
attributed to a generalised disorder of vascular and endothelial function. We
teeted this hypothesis by assessing the nitric oxide and endothelin systems
in the forearm vaecular bed.
Ten syndrome X patients (normal smooth coronary arteries, 22 mm ST
segment depression on exercise testing and typical anginal chest pain) were
compared with healthy age and sex matched controls. Following brachial
artery cannulation, forearm blood flow (FBF) was measured ueing venous
occlusion plathysmography. Substance P (Sub P) at 1, 2 and 4 pmo!lmin,
acetylcholine (ACh) at 5, Ioand 20 @rein, and sodium nitroprusside (SNP)
at 1,3 and 6 w~min were infused for 6 min at each dose. The agonists were
separated by 20 min saline infusions and given in random order. Finally, a
10 min infusion of L-NMMA (nitric oxide synthase inhibitor) was given at 4
pmollmirr. On aeparate days, at least one month apart, BQ-123 (endothe-
Iin A receptor antagonist) at 100 nmol/min, and endothelin-1 (ET-1) at 5
pmol/min, were infused for 80 min each. Dose-dependent increases in FBF
were achieved with ACh, Sub P & SNP (ps 0.01). There were no significant
differences in responses to ACh, Sub P, SNP or L-NMMA between the two
groups. BQ-123 caused a slow onset vasodilatation (p -= 0.001) with an
increase in FBF of 42 + 6Y0in syndrome X and 40 + 10% in controls (no
significant between group differences). However, ET-1 caused a slow onset
vaaoconatrfction(p < 0.001) with a reduction in FBF of 21 +4% in syndrome
X and 36 + 3% in controls (p c 0.001). Plaama ET-1 concentrations tended
to be higher in syndrome X (4.9 VS4.Opg/ml; p = 0.1) and tha vasoconstric-
tion caused by ET-1 infusion correlated with plasma ET-1 concentrations (r
= 0.51: o = 0,04).
We”have fo;nd that patients with syndrome X have normal nitric oxide
activity and basal endogenous ET-1 vascular tone. However, there is a
reduced sensitivity to exogenous ET-1 which may reflect the higher ET-t
levels arrd/oralterations in receptor expression.
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Cardiomyopathy:ClinicalObservationsina Large
Kindred
A. Kumarl, J. Zhang2, V.J. Ferrans3, K. Horiba$, F.J. Fricker2,
M.R. Wallace2. i Urriversh’yofTexasMedical Branch, Galveaton, TX, USA,
2 Unive@y of F/otida, Gainesville, FL, USA, 3Nationa//nst/tutes of Heaffh,
Bethe6da, MD, USA
Restrictive cardiomyopathy (RC) is characterized by decreaaed compliance
of myocardium. RC is usually sporadic, although it can cccur in familial form
secondary to amyloidosis or hemochromatosis. Abnormal accumulation of
deamin, an intermediate filament protein which is a major component of the
cytoakeletoninmyocytes, can Ieadtoskeletal myopathy and RC. Wedescrlbe
a large 4-generation Caucasian family with RC segregating as an autosomal
dominant trait. Of the 34 members of the family, 19ware diagnosed as having
RC (on the basis of clinical, echocardiographic and cardiac catheterization
findings in 7, echocardiographic or electrocardiographic evidence of signifi-
cant atrial enlargement in 6, and typical clinical findings in S patients). Age
range for onset of symptoms was from 3 to 60 years. Common problema
included axerclse intolerance, anasarca and chronic atrial fibrillation. 2 pa-
tients received heart transplants and are doing well. Myocardial biopsy in 4
individualsshowedfocal nonspacificfibrosis on routine morphologic examina-
tion. Amyloidosisand hemochromatoais wera excluded by special stains. lm-
munohistochemical and electron microscopic study in one individual showed
excessive and abnormal granular deposits of desmin throughout the cyto-
plaam, rather than the normal pattern of 10 nm intermediate fiiamants located
at the levels of tha Z bands. We suggest that an abnormality of desmin struc-
ture ordistribution within the cardiac muscle cells, may have caused RC in this
family, and that a single gene is responsible for this disorder. Wearecurrently
performing genetic Iinkagaanalysis toanswerthis question.
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Relativesat Riskof DiletedCardiomyopathy
A.L.P. Caforio12, M.K. Baig2, J.H. Goldman 2, A.J. Havan2, K. Reardon2,
W.J. McKenna2. 1Depts of Cardiology, University of Padua, Padua, /,
2 Cardiological Sciences, St. George’s Hospital, London, UK
Cardiac and disease specific autoantitmdiea (Abs) are found by immunofluo-
rescence (lFL) in patients with idiopathic dilated cardiomyopathy (DCM) and
their firat degree relatives. In aufoimmune disease, autoantibodies may be
detected yeara before disease onset and identify symptom-free relatives at
rtak. To assess the rola of cardiac Abs as potential markers of DCM eua-
ceptibility, we performed cardiological and immunological screening in 445
apparently healthy relatives (224 male, aged 36 + 16 yra) at baseline, and
at follow-up (mean follow-up 33+ 60 mo) in 108 relatives who had baseline
positive antibody test and/or 2-d echocardiographic abnormalities. These
included left ventricular enlargement (LVE), e.g. left ventricular enddias.
tolicdimension (LVDD) >112% predicted, or depressed fractional shortening
(DFS) (<25%). Cardiac Abs were detected by IFL on human heart; all sera
were tested blindly from diagnosis. At baseline, 48 of the 108 relatives had a
normal echocardiogram, 51 had LVE and 9 DFS; 61 were antibody positive.
At follow-up, disease progressad in 10 of them (from DFS to DCM in 1; from
normal to LVE in 6, to DFS in 1 and to DCM in 1; from LVE to DCM in 1).
The 10 relativea who progressed had higher mean LVDO (57+9 mm) and
lower FS (26+ 9%) at follow-up compared to their baseline measurements
(53 + 4 mm, p = 0.08; 31 + 7%, p. 0.04), as well as compared to those of
the 96 remaining relatives at follow-up (51 + 5 mm, p = 0.004; 33 A 5%, p
= 0.0001). The finding of cardiac Abs at baseline was more common among
relatives who progressed (9/10, 90%) compared tothoae who did not (52/96,
53%, p = 0.02). Cardiac Abs may identify symptom-free relatives at risk of
progression to DCM. Extendad follow-up is warranted.
